stockportfolio.pro
Stocks / ELAN vs RVTY
ELAN vs RVTY
Elanco Animal Health Incorporated and Revvity, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Elanco Animal Health Incorporated (ELAN) | Revvity, Inc. (RVTY) | |
|---|---|---|
| Market cap | $11.5B | $11.6B |
| Revenue (latest FY) | $4.71B | $2.86B |
| Net income (latest FY) | $-232.00M | $241.20M |
| Revenue growth (5y CAGR) | 7.6% | -5.5% |
| Net margin | -4.9% | 8.4% |
| Return on equity | -3.5% | 3.3% |
| P/E ratio | — | 50.1 |
| Dividend yield | — | 0.3% |
| Profitable years (of last 10) | 3 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ELAN — free Open RVTY — freeFrequently asked questions
Which is bigger, ELAN or RVTY?
Revvity, Inc. is larger by market capitalization — $11.6B versus $11.5B.
Which grows faster, ELAN or RVTY?
Over the last five fiscal years, Elanco Animal Health Incorporated grew revenue faster — 7.6%/yr versus -5.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.